Literature DB >> 7534530

[Tetanus vaccination. Evaluation of a program of health promotion in a family medicine unit].

M Labrecque1, C Rhéault, M Bergeron, S Bergeron, F Paquet.   

Abstract

OBJECTIVE: To assess the effectiveness of a tetanus immunization poster at a medical clinic in encouraging patients to request immunization against tetanus with d2T5.
DESIGN: Quasi-experimental study.
SETTING: The Family Medicine Unit (F.M.U.) at the Centre hospitalier de l'Université Laval (C.H.U.L.), a tertiary hospital in the region of Quebec City. PARTICIPANTS: All patients over 7 years of age at CHUL's FMU between February 22 and March 19, 1993.
INTERVENTIONS: Poster promoting tetanus immunization displayed in waiting room during test weeks 2 and 4 and withdrawn during control weeks 1 and 3. MAIN OUTCOME MEASURE: Proportion of patients vaccinated with d2T5.
RESULTS: The proportion of patients vaccinated during the test weeks was the same as the proportion vaccinated during the control weeks. Week 1: 1/507 (0.20); Week 2: 1/394 (0.25); Week 3: 1/441 (0.23); Week 4: 1/486 (0.21).
CONCLUSION: The presence of the posters in the waiting room had no impact on tetanus immunization at CHUL's FMU.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534530      PMCID: PMC2145964     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  10 in total

1.  [Not Available].

Authors:  M Samson; L G Latulippe; M Labrecque
Journal:  Can Fam Physician       Date:  1992-05       Impact factor: 3.275

2.  [Not Available].

Authors:  L G Latulippe; P Beaupré; J Dorion; L Pelletier; C Rhéaume
Journal:  Can Fam Physician       Date:  1991-10       Impact factor: 3.275

3.  Effectiveness of publicity campaign encouraging earlier referral of hearing loss in adults.

Authors:  R L King; B Barry; D N Brooks
Journal:  Br Med J (Clin Res Ed)       Date:  1987-05-23

4.  Spontaneous remission from the problematic use of substances: an inductive model derived from a comparative analysis of the alcohol, opiate, tobacco, and food/obesity literatures.

Authors:  R Stall; P Biernacki
Journal:  Int J Addict       Date:  1986-01

5.  An assessment of the use of an advertisement and a poster in health education.

Authors:  A M Batten; C McEwan
Journal:  Health Bull (Edinb)       Date:  1972-04

6.  Anyone for tetanus?

Authors:  J G Howie
Journal:  BMJ       Date:  1988-09-03

7.  Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984.

Authors:  R W Sutter; S L Cochi; E W Brink; B I Sirotkin
Journal:  Am J Epidemiol       Date:  1990-01       Impact factor: 4.897

8.  Factors affecting the use of vaccines: considerations for immunization program planners.

Authors:  M A Riddiough; J S Willems; C R Sanders; K Kemp
Journal:  Public Health Rep       Date:  1981 Nov-Dec       Impact factor: 2.792

9.  Are we wasting time in out-patients departments?

Authors:  F J Matthews; C S Probert; T Battcock; S D Frisby; M Chandar; J F Mayberry
Journal:  Public Health       Date:  1991-05       Impact factor: 2.427

10.  The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.

Authors:  G J Gormley; E Stoner; R C Bruskewitz; J Imperato-McGinley; P C Walsh; J D McConnell; G L Andriole; J Geller; B R Bracken; J S Tenover
Journal:  N Engl J Med       Date:  1992-10-22       Impact factor: 91.245

  10 in total
  2 in total

1.  Effect of an audiovisual message for tetanus booster vaccination broadcast in the waiting room.

Authors:  Caroline Eubelen; Fannette Brendel; Jean-Luc Belche; Anne Freyens; Sophie Vanbelle; Didier Giet
Journal:  BMC Fam Pract       Date:  2011-09-28       Impact factor: 2.497

2.  Randomized controlled trial on promoting influenza vaccination in general practice waiting rooms.

Authors:  Christophe Berkhout; Amy Willefert-Bouche; Emmanuel Chazard; Suzanna Zgorska-Maynard-Moussa; Jonathan Favre; Lieve Peremans; Grégoire Ficheur; Paul Van Royen
Journal:  PLoS One       Date:  2018-02-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.